Cargando…
Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy
Pathological cardiac hypertrophy is characterized by an abnormal increase in cardiac muscle mass in the left ventricle, resulting in cardiac dysfunction. Although various therapeutic approaches are being continuously developed for heart failure, several studies have suggested natural compounds as no...
Autores principales: | Lee, Chang Youn, Park, Han Ki, Lee, Bok-Sim, Jeong, Seongtae, Hyun, Sung-Ae, Choi, Jung-Won, Kim, Sang Woo, Lee, Seahyoung, Lim, Soyeon, Hwang, Ki-Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697794/ https://www.ncbi.nlm.nih.gov/pubmed/33198253 http://dx.doi.org/10.3390/molecules25225279 |
Ejemplares similares
-
Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
por: Jeong, Seongtae, et al.
Publicado: (2020) -
Effect of ligustilide on Ang II-induced hypertrophy in cardiomyocytes and the potential mechanisms
por: LU, QUN, et al.
Publicado: (2014) -
MicroRNA-26a/b-5p promotes myocardial infarction-induced cell death by downregulating cytochrome c oxidase 5a
por: Jung, Seung Eun, et al.
Publicado: (2021) -
Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3
por: Yahara, Yasuhito, et al.
Publicado: (2016) -
EPC-Derived Microvesicles Protect Cardiomyocytes from Ang II-Induced Hypertrophy and Apoptosis
por: Gu, Shenhong, et al.
Publicado: (2014)